February 9, 2009 – Some patients who suffer a stroke as a result of a blockage in an artery in the brain may benefit from a clot-busting drug nine or more hours after the onset of symptoms, according to findings published in the online edition of Radiology.

February 9, 2009 - Emory University cardiologists are testing a modification of angioplasty known as postconditioning, designed to reduce permanent damage to the heart muscle after a heart attack.

February 6, 2009 - Biosense Webster Inc., a Johnson & Johnson company, today said the FDA granted market approval to the NaviStar ThermoCool Catheter for the treatment of drug refractory recurrent symptomatic paroxysmal atrial fibrillation, when used with compatible 3D electroanatomic mapping systems.

February 6, 2009 – The FDA has approved St. Jude Medical Inc.’s medical device system that allows a single defibrillation lead connection between a cardiac resynchronization therapy defibrillator (CRT-D) and the leads that send electrical impulses to the heart to treat the symptoms of heart failure.


February 6, 2009 - Medtronic Inc. today said it completed the acquisition of Ablation Frontiers Inc. for an initial payment of $225 million plus potential additional payments contingent upon achievement of certain clinical milestones.

February 6, 2009 - Boston Scientific Corp. yesterday submitted to the FDA the final modules of the company’s pre-market approval (PMA) applications for both its TAXUS Liberte Atom Paclitaxel-Eluting Coronary Stent System and its TAXUS Liberte Long Paclitaxel-Eluting Coronary Stent System.

February 6, 2009 - Premier Purchasing Partners yesterday announced new agreements for drug-eluting coronary stents with Abbott Laboratories Inc., Abbott Vascular and Cordis Corp.

The 13-month agreements went into effect Jan. 1, 2009 and are available to acute care and continuum of care members of the Premier healthcare alliance.

February 5, 2009 - Resuscitation device maker ZOLL Medical Corp. said this week it filed a lawsuit against Alsius Corp. and Alsius Medical Corp. in the Central District of California alleging infringement of its patents for catheter-based induced hypothermia devices.

February 5, 2009 - BeneChill Inc. this week started the PRINCE (Pre-Resuscitation Intra-Nasal Cooling Effectiveness) study, a randomized study to determine whether intra-nasal cooling using the RhinoChill device during resuscitation increases patient and survival rates, including ischemic events such as cardiac arrest and stroke.

February 5, 2009 - AGA Medical Corp. last week said following its previous favorable structural heart occluder patent infringement final ruling by the German court of appeals over Occlutech GmbH of Jena, Germany, it has calculated and notified Occlutech of the amount of damages that it will seek from Occlutech based on the court’s ruling.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now